| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |